Evidence map›Paper›PMID 33616039›Full record

ArticleeLife2021

Dichloroacetate reverses sepsis-induced hepatic metabolic dysfunction.

Rabina Mainali, Manal Zabalawi, David Long, Nancy Buechler, Ellen Quillen, Chia-Chi Key, Xuewei Zhu, John S Parks, Cristina Furdui, Peter W Stacpoole and 3 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 75 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Sepsis and the immunometabolic inflammatory response.npj metabolic health and disease · 2026
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Rabina Mainali *Department of Pathology, Section on Comparative Medicine, Wake Forest School of Medicine, Winston-Salem, United States.
Manal Zabalawi *Department of Internal Medicine, Section on Molecular Medicine, Wake Forest School of Medicine, Winston-Salem, United States.
David LongDepartment of Internal Medicine, Section on Molecular Medicine, Wake Forest School of Medicine, Winston-Salem, United States.
Nancy BuechlerDepartment of Pathology, Section on Comparative Medicine, Wake Forest School of Medicine, Winston-Salem, United States.
Ellen QuillenDepartment of Internal Medicine, Section on Molecular Medicine, Wake Forest School of Medicine, Winston-Salem, United States.
Chia-Chi KeyDepartment of Internal Medicine, Section on Molecular Medicine, Wake Forest School of Medicine, Winston-Salem, United States.ORCID 0000-0003-0669-2936
Xuewei ZhuDepartment of Internal Medicine, Section on Molecular Medicine, Wake Forest School of Medicine, Winston-Salem, United States.
John S ParksDepartment of Internal Medicine, Section on Molecular Medicine, Wake Forest School of Medicine, Winston-Salem, United States.ORCID 0000-0002-5227-8915
Cristina FurduiDepartment of Internal Medicine, Section on Molecular Medicine, Wake Forest School of Medicine, Winston-Salem, United States.
Peter W StacpooleDivision of Endocrinology, Diabetes and Metabolism, Department of Medicine and Department of Biochemistry and Molecular Biology, University of Florida College of Medicine, Gainesville, United States.
Jennifer MartinezImmunity, Inflammation, and Disease Laboratory, National Institute of Environmental Health Sciences (NIEHS), National Institutes of Health (NIH), Research Triangle Park, Bethesda, United States.
Charles E McCallDepartment of Internal Medicine, Section on Molecular Medicine, Wake Forest School of Medicine, Winston-Salem, United States.
Matthew A QuinnDepartment of Pathology, Section on Comparative Medicine, Wake Forest School of Medicine, Winston-Salem, United States.ORCID 0000-0002-3528-6569
Wake Forest University · USNational Institutes of Health · USUniversity of Florida · US

Funding

Characterization of the molecular mechanisms of LC3-associated phagocytosis and its role in disease pathogenesisZIAES103286 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI MARTINEZ, JENNIFER · 2015 to 2021
$9.2M
NF-kB and Chromatin Changes in Human SepsisR01AI065791 · NIAID · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI MCCALL, CHARLES EMORY · 2006 to 2015
$4.3M
The Role of Hepatocyte ABCA1 in Lipid Mobilization and TransportR01HL119962 · NHLBI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI PARKS, JOHN S · 2013 to 2022
$3.9M
Redox control over metabolism and mitochondrial bioenergetics directs the course of acute inflammation and sepsisR35GM126922 · NIGMS · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI MCCALL, CHARLES EMORY · 2018 to 2022
$2.1M
The role of SLC37A2, a glucose 6 phosphate transporter, in inflammation and metabolic diseasesR01HL132035 · NHLBI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI ZHU, XUEWEI · 2016 to 2020
$1.9M
Mitochondrial Biogenesis is Regulated by RelB During InflammationR01GM102497 · NIGMS · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI MCCALL, CHARLES EMORY · 2014 to 2017
$1.2M
Role of Hepatic GDPD3 in Mechanisms of Lipid MetabolismK01DK117069 · NIDDK · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI KEY, CHIA-CHI CHUANG · 2018 to 2021
$467k
Integrative multi-omic investigation of age-related changes in trabecular boneK01AG056663 · NIA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI QUILLEN, ELLEN ELIZABETH · 2018 to 2021
$377k
NHLBI NIH HHS R01 HL119962NHLBI NIH HHS R01 HL132035NIAID NIH HHS R01 AI065791NIA NIH HHS K01 AG056663NIDDK NIH HHS K01 DK117069NIEHS NIH HHS 1ZIAES10328601NIGMS NIH HHS R01 GM102497NIGMS NIH HHS R35 GM126922
6 · The paper itself

Abstract

Metabolic reprogramming between resistance and tolerance occurs within the immune system in response to sepsis. While metabolic tissues such as the liver are subjected to damage during sepsis, how their metabolic and energy reprogramming ensures survival is unclear. Employing comprehensive metabolomic, lipidomic, and transcriptional profiling in a mouse model of sepsis, we show that hepatocyte lipid metabolism, mitochondrial tricarboxylic acid (TCA) energetics, and redox balance are significantly reprogrammed after cecal ligation and puncture (CLP). We identify increases in TCA cycle metabolites citrate, cis-aconitate, and itaconate with reduced fumarate and triglyceride accumulation in septic hepatocytes. Transcriptomic analysis of liver tissue supports and extends the hepatocyte findings. Strikingly, the administration of the pyruvate dehydrogenase kinase (PDK) inhibitor dichloroacetate reverses dysregulated hepatocyte metabolism and mitochondrial dysfunction. In summary, our data indicate that sepsis promotes hepatic metabolic dysfunction and that targeting the mitochondrial PDC/PDK energy homeostat rebalances transcriptional and metabolic manifestations of sepsis within the liver.

Indexed as

AnimalsCitric Acid CycleDichloroacetic AcidDisease Models, AnimalEnergy MetabolismHepatocytesMaleMiceMice, Inbred C57BLMitochondriaOxidation-ReductionPyruvate Dehydrogenase Acetyl-Transferring KinaseSepsisDichloroacetic AcidPyruvate Dehydrogenase Acetyl-Transferring Kinaseimmunologyinflammationlivermetabolismmousesepsissteatosis

Identifiers

PMID33616039
PMCPMC7901874
OpenAlexW3131347812

What Socratic holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.